These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 36421632)
1. Risk Analysis and Assessment of Lipid Abnormalities as the Earliest Complication in Newly Diagnosed Diabetic and Non-Diabetic Individuals of a Local Population. Baig ZA; Rashid A; Majeed A; Masood Z; Faryal A; Khan ZA; Razaq A Healthcare (Basel); 2022 Nov; 10(11):. PubMed ID: 36421632 [TBL] [Abstract][Full Text] [Related]
2. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome. Nesto RW Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526 [TBL] [Abstract][Full Text] [Related]
3. Lipid and Lipoprotein Profile in HIV-Infected and Non-Infected Diabetic Patients: A Comparative Cross-Sectional Study Design, Southwest Ethiopia. Woyesa S; Mamo A; Mekonnen Z; Abebe G; Gudina EK; Milkesa T HIV AIDS (Auckl); 2021; 13():1119-1126. PubMed ID: 34992470 [TBL] [Abstract][Full Text] [Related]
4. Association of Fasting Plasma Glucose and Serum Lipids in Type 2 Diabetics. Khadke S; Harke S; Ghadge A; Kulkarni O; Bhalerao S; Diwan A; Pankaj M; Kuvalekar A Indian J Pharm Sci; 2015; 77(5):630-4. PubMed ID: 26798181 [TBL] [Abstract][Full Text] [Related]
5. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes. Temelkova-Kurktschiev T; Hanefeld M Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):75-9. PubMed ID: 15031770 [TBL] [Abstract][Full Text] [Related]
6. C-reactive protein is associated with low-density lipoprotein cholesterol and obesity in type 2 diabetic Sudanese. Dongway AC; Faggad AS; Zaki HY; Abdalla BE Diabetes Metab Syndr Obes; 2015; 8():427-35. PubMed ID: 26379442 [TBL] [Abstract][Full Text] [Related]
7. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study. Ozder A Lipids Health Dis; 2014 Dec; 13():183. PubMed ID: 25481115 [TBL] [Abstract][Full Text] [Related]
8. Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study. Siegel RD; Cupples A; Schaefer EJ; Wilson PW Metabolism; 1996 Oct; 45(10):1267-72. PubMed ID: 8843183 [TBL] [Abstract][Full Text] [Related]
9. Pattern of dyslipidemia and evaluation of non-HDL cholesterol as a marker of risk factor for cardiovascular disease in type 2 diabetes mellitus. Pandeya A; Sharma M; Regmi P; Basukala A; Lamsal M Nepal Med Coll J; 2012 Dec; 14(4):278-82. PubMed ID: 24579534 [TBL] [Abstract][Full Text] [Related]
10. Serum lipid profile of Nigerian diabetics with end stage renal disease. Agaba EI; Duguru M; Agaba PA; Angbazo D West Afr J Med; 2005; 24(4):305-8. PubMed ID: 16483045 [TBL] [Abstract][Full Text] [Related]
11. Importance of high-density lipoprotein cholesterol levels in elderly diabetic individuals with type IIb dyslipidemia: A 2-year survey of cardiovascular events. Ina K; Hayashi T; Araki A; Kawashima S; Sone H; Watanabe H; Ohrui T; Yokote K; Takemoto M; Kubota K; Noda M; Noto H; Ding QF; Zhang J; Yu ZY; Yoon BK; Nomura H; Kuzuya M; Geriatr Gerontol Int; 2014 Oct; 14(4):806-10. PubMed ID: 24215618 [TBL] [Abstract][Full Text] [Related]
12. Lipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: results of the 8.6 years follow-up of a population based cohort study. Tohidi M; Hatami M; Hadaegh F; Safarkhani M; Harati H; Azizi F Lipids Health Dis; 2010 Jan; 9():6. PubMed ID: 20096127 [TBL] [Abstract][Full Text] [Related]
13. [Do we reach target lipid levels in diabetic and non-diabetic patients with previous myocardial infarction?]. Aleksić E; Stamenković R; Lapcević M; Deljanin-Ilić M; Djordjević D; Tasić I Srp Arh Celok Lek; 2011; 139(1-2):30-6. PubMed ID: 21568080 [TBL] [Abstract][Full Text] [Related]
14. Association of trace metal elements with lipid profiles in type 2 diabetes mellitus patients: a cross sectional study. Wolide AD; Zawdie B; Alemayehu T; Tadesse S BMC Endocr Disord; 2017 Oct; 17(1):64. PubMed ID: 29029608 [TBL] [Abstract][Full Text] [Related]
15. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus. Udawat H; Goyal RK Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472 [TBL] [Abstract][Full Text] [Related]
16. The relationship between dyslipidemia and inflammation among adults in east coast China: A cross-sectional study. Hong N; Lin Y; Ye Z; Yang C; Huang Y; Duan Q; Xie S Front Immunol; 2022; 13():937201. PubMed ID: 36032093 [TBL] [Abstract][Full Text] [Related]
17. Lipoprotein abnormalities and their consequences for patients with type 2 diabetes. Krentz AJ Diabetes Obes Metab; 2003 Nov; 5 Suppl 1():S19-27. PubMed ID: 14984018 [TBL] [Abstract][Full Text] [Related]
18. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus. Toth PP; Simko RJ; Palli SR; Koselleck D; Quimbo RA; Cziraky MJ Cardiovasc Diabetol; 2012 Sep; 11():109. PubMed ID: 22978715 [TBL] [Abstract][Full Text] [Related]
19. Corrected Serum Ionized Calcium as a Risk Factor Related to Adult Dyslipidemia. Yun K; Zhang S; Yang X; Man D; Yao J; Wang W; Han X Front Cardiovasc Med; 2022; 9():916991. PubMed ID: 35872922 [TBL] [Abstract][Full Text] [Related]
20. Correlation between the triglyceride-to-high-density lipoprotein cholesterol ratio and other unconventional lipid parameters with the risk of prediabetes and Type 2 diabetes in patients with coronary heart disease: a RCSCD-TCM study in China. Yang T; Liu Y; Li L; Zheng Y; Wang Y; Su J; Yang R; Luo M; Yu C Cardiovasc Diabetol; 2022 Jun; 21(1):93. PubMed ID: 35659300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]